Vistin Pharma

Vistin Pharma is a company listed under the stock ticker VP4 (NO).

View the org chart displaying its 11 main executives

Most searched biographies at Vistin Pharma

• Magnus Tolleshaug, Chief Executive Officer
• ÅSe Musum, Board Member
• Espen Lia Gregoriussen, Director, Employee Representative

Popular executive movements at Vistin Pharma

• Magnus Tolleshaug who is Interim Chief Executive Officer, will be promoted to Chief Executive Officer on Jan. 1, 2024  (posted on October 25 2023).

Create your alert
to follow the executive moves at Vistin Pharma.

Vistin Pharma has 1,860 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• MedMen has filed for bankruptcy protection  (posted on April 28 2024).
• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Danilo Cicmil - Supervisory Board Member at Galenika
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by Vistin Pharma

Social media about Vistin Pharma

• Vistin Pharma on Wikipedia, Google News & Yahoo Finance
• Vistin Pharma on LinkedIn, Twitter & YouTube

Contact by email its executives including ÅSe Musum

Call Vistin Pharma at +47 ...

View the org chart

Register to receive your alert

Report an error